Zahra Jawad

Zahra Jawad is the founder of Creasallis, looking to improve how antibodies penetrate into solid tumours without compromising their manufacturability. Zahra has worked for over 20 years in the Cambridge biotech/pharma scene, engineering antibodies for a number of therapeutic areas. She has led teams and programmes from early-stage discovery towards Investigational New Drug (IND). Zahra did her PhD in protein engineering at the University of Cambridge and BSc at King's College London.